scholarly journals Suspected adverse reaction to erysipelas vaccine in sheep

2020 ◽  
Vol 186 (18) ◽  
pp. 610.1-611
Author(s):  
Cornelia Bidewell ◽  
Amanda Carson ◽  
Gillian Diesel ◽  
Tobias Floyd
Keyword(s):  
Adverse Reaction ◽  
Suspected Adverse Reaction

Neutrophilic dermatitis and immunemediated haematological disorders in a dog: suspected adverse reaction to carprofen

2005 ◽  
Vol 46 (5) ◽  
pp. 237-242 ◽  
Author(s):  
P. J. Mellor ◽  
A. J. A. Roulois ◽  
M. J. Day ◽  
B. A. Blacklaws ◽  
S. J. Knivett ◽  
...  
Keyword(s):  
Adverse Reaction ◽  
Suspected Adverse Reaction ◽  
Haematological Disorders

scholarly journals Renal failure as a suspected adverse reaction to benoxaprofen

1982 ◽  
Vol 58 (679) ◽  
pp. 317-318 ◽  
Author(s):  
W. Fine ◽  
R. C. Tallis ◽  
K. M. Osman
Keyword(s):  
Renal Failure ◽  
Adverse Reaction ◽  
Suspected Adverse Reaction

Suspected adverse reaction to compounded preparations prescribed for weight loss: two cases of cerebral venous thrombosis

2020 ◽  
Vol 13 (3) ◽  
pp. e233746 ◽  
Author(s):  
Beatrice Mainoli ◽  
Mariana Carvalho Dias ◽  
Patricia Canhão ◽  
Mário Miguel Rosa
Keyword(s):  
Weight Loss ◽  
Adverse Reaction ◽  
Venous Thrombosis ◽  
Adverse Drug Reactions ◽  
Oral Contraceptives ◽  
Cerebral Venous Thrombosis ◽  
Drug Reactions ◽  
Suspected Adverse Reaction ◽  
Life Threatening ◽  
Active Substances

We report two cases of cerebral venous thrombosis associated with the use of compounded preparations containing several active substances prescribed for weight loss. In both cases there is suspicion of additive/synergic interaction with oral contraceptives. The adverse drug reactions were considered serious, being life-threatening and causing hospitalisation for days.

Assembly of the Heparin Removal Device for patients with suspected adverse reaction to protamine sulphate

Perfusion ◽  
2000 ◽  
Vol 15 (5) ◽  
pp. 453-456
Author(s):  
D Jegger ◽  
H T Tevaearai ◽  
J Horisberger ◽  
X M Mueller ◽  
I Seigneuil ◽  
...  
Keyword(s):  
Adverse Reaction ◽  
Adverse Reactions ◽  
Ex Vivo ◽  
Artery Bypass ◽  
Bypass Graft ◽  
Postoperative Bleeding ◽  
Protamine Sulphate ◽  
Suspected Adverse Reaction ◽  
Alternative Means ◽  
Activated Coagulation Time

Protamine sulphate is routinely used after cardiopulmonary bypass (CPB) to restore the patient’s baseline coagulatory state. However, adverse reactions are encountered, and alternative means to neutralize heparin are, therefore, necessary. The Heparin Removal Device (HRD) constitutes an extracorporeal circuit that allows ex vivo deheparinization by mean of a polycationic ligand that binds heparin molecules. This paper presents the setup of the HRD circuit. It is illustrated by the report of a 68-year-old man with a known severe crustacean allergy. The patient (78 kg, 170 cm) was admitted for elective coronary artery bypass graft surgery. It was decided that the HRD would be used as a precaution in order to avoid the risks of using protamine sulphate. The CPB time and aortic crossclamp time were 70 and 40 min, respectively. At the end of CPB, the device was inserted and processing started. Activated coagulation time values were monitored over a 130 min period and diminished from 480 to 300 s after 45 min, 220 s after 90 min, and settled at 150 s. Haemostasis was acceptable and processing stopped. The operation was terminated and the patient transferred to the intensive care unit. Clinical evolution was excellent, with minimal postoperative bleeding. The HRD presents an alternative to protamine sulphate when this drug is contraindicated for a certain patient population who might have a suspected, known or emergency adverse reaction.

Penicillin: suspected adverse reaction

1980 ◽  
Vol 106 (9) ◽  
pp. 207-208 ◽  
Author(s):  
A. Marshall
Keyword(s):  
Adverse Reaction ◽  
Suspected Adverse Reaction

Voluntary suspected adverse reaction scheme

1988 ◽  
Vol 123 (22) ◽  
pp. 584-584 ◽  
Author(s):  
A. Gray ◽  
C. Evans
Keyword(s):  
Adverse Reaction ◽  
Reaction Scheme ◽  
Suspected Adverse Reaction
Sign in / Sign up

Export Citation Format

Share Document